AlphaMark Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,486	Closed	-$328K	–	641
2024 Q3	$328K	Buy	+16,486	New	+$328K	0.11%	168
2019 Q3	–	Sell	-2,208	Closed	-$8K	–	488
2019 Q2	$8K	Buy	+2,208	New	+$8K	﹤0.01%	354